QXO (QXO) had the best month between July 1, 2011 and December 31, 2012 by a mid-cap US stock in March 2012, returning 710.8%.
| ASSET | MONTH | % RETURN |
|---|---|---|
QXO (QXO) | March 2012 | 710.81% |
TG Therapeutics (TGTX) | February 2012 | 277.77% |
Green Brick Partners (GRBK) | October 2011 | 155.02% |
QXO (QXO) | January 2012 | 150% |
Catalyst Pharmaceuticals (CPRX) | July 2012 | 145.14% |
ACADIA Pharmaceuticals (ACAD) | November 2012 | 121.28% |
Patrick Industries (PATK) | March 2012 | 97.24% |
Marathon Digital (MARA) | May 2012 | 96.08% |
Amicus Therapeutics (FOLD) | January 2012 | 83.1% |
Marathon Digital (MARA) | June 2012 | 80% |
Mr Cooper (COOP) | December 2012 | 78.72% |
Riot Blockchain (RIOT) | September 2012 | 78.71% |
Globalstar (GSAT) | October 2011 | 76.62% |
Supernus Pharmaceuticals (SUPN) | June 2012 | 74.95% |
TG Therapeutics (TGTX) | December 2012 | 73.33% |
Iovance Biotherapeutics (IOVA) | July 2012 | 71.43% |
Globalstar (GSAT) | September 2012 | 70.37% |
Green Brick Partners (GRBK) | September 2012 | 69.57% |
TG Therapeutics (TGTX) | January 2012 | 66.67% |
Celsius (CELH) | March 2012 | 66.63% |
Spectrum Brands (SPB) | June 2012 | 65.04% |
Terex (TEX) | October 2011 | 63.94% |
Geron (GERN) | August 2012 | 61.4% |
QXO (QXO) | October 2011 | 60% |
QXO (QXO) | December 2012 | 60% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
